Small fibre neuropathy in Fabry disease: a human-derived neuronal in vitro disease model and pilot data
Authors:
Open Access
- 1 March 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Brain Communications
- Vol. 6 (2) , fcae095
Abstract
Acral burning pain triggered by fever, thermal hyposensitivity and skin denervation are hallmarks of small fibre neuropathy in Fabry disease, a life-threatening X-linked lysosomal storage disorder. Variants in the gene encoding alpha-galactosidase A may lead to impaired enzyme activity with cellular accumulation of globotriaosylceramide. To study the underlying pathomechanism of Fabry-associated small fibre neuropathy, we generated a neuronal in vitro disease model using patient-derived induced pluripotent stem cells from three Fabry patients and one healthy control. We further generated an isogenic control line via gene editing. We subjected induced pluripotent stem cells to targeted peripheral neuronal differentiation and observed intra-lysosomal globotriaosylceramide accumulations in somas and neurites of Fabry sensory neurons using super-resolution microscopy. At functional level, patch-clamp analysis revealed a hyperpolarizing shift of voltage-gated sodium channel steady-state inactivation kinetics in isogenic control neurons compared with healthy control neurons (P < 0.001). Moreover, we demonstrate a drastic increase in Fabry sensory neuron calcium levels at 39°C mimicking clinical fever (P < 0.001). This pathophysiological phenotype was accompanied by thinning of neurite calibres in sensory neurons differentiated from induced pluripotent stem cells derived from Fabry patients compared with healthy control cells (P < 0.001). Linear–nonlinear cascade models fit to spiking responses revealed that Fabry cell lines exhibit altered single neuron encoding properties relative to control. We further observed mitochondrial aggregation at sphingolipid accumulations within Fabry sensory neurites utilizing a click chemistry approach together with mitochondrial dysmorphism compared with healthy control cells. We pioneer pilot insights into the cellular mechanisms contributing to pain, thermal hyposensitivity and denervation in Fabry small fibre neuropathy and pave the way for further mechanistic in vitro studies in Fabry disease and the development of novel treatment approaches.Keywords
Funding Information
- German Research Foundation (DFG: UE171/3-1)
- Interdisciplinary Center for Clinical Research
- University of Würzburg (project N375)
- Collaborative Research Center
- DFG (project A10, KFO5001)
- European Research Council (KFO5001, RTG2581, UE171/15-1, Ma 2528/8-1, SFB 1525, 453989101)
- Austrian Science Fund FWF (M3062-B)
This publication has 84 references indexed in Scilit:
- Characterization of cellular phenotypes in neurons derived from induced pluripotent stem cells of male patients with Fabry diseaseJournal of Inherited Metabolic Disease, 2022
- Patient‐derived in vitro skin models for investigation of small fiber pathologyAnnals of Clinical and Translational Neurology, 2019
- Reduction of skin innervation is associated with a severe fibromyalgia phenotypeAnnals of Neurology, 2019
- Lysosomal glycosphingolipid catabolism by acid ceramidase: formation of glycosphingoid bases during deficiency of glycosidasesFEBS Letters, 2016
- Personalized Medicine: Cell and Gene Therapy Based on Patient-Specific iPSC-Derived Retinal Pigment Epithelium Cells2015
- Effective clearance of GL‐3 in a human iPSC‐derived cardiomyocyte model of Fabry diseaseJournal of Inherited Metabolic Disease, 2014
- Mitochondrial function and morphology are impaired in parkin‐mutant fibroblastsAnnals of Neurology, 2008
- Pathological findings in a patient with Fabry disease who died after 2.5 years of enzyme replacementVirchows Archiv, 2005
- The early clinical phenotype of Fabry disease: a study on 35 European children and adolescentsEuropean Journal of Pediatrics, 2003
- Enzyme Replacement Therapy in Fabry DiseaseJAMA, 2001